Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $5.22 | Prev. Close $5.12 | Circuit Range N/A |
Day Range $5.17 - $5.82 | Year Range $0.05 - $7.04 | Volume 1,005 |
Average Traded $5.46 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
01-Jul-26 | $5.22 | $5.67 | +0.00% |
01-Jul-26 | $5.22 | $5.67 | -5.89% |
29-Jun-26 | $6.03 | $6.03 | -4.74% |
26-Jun-26 | $6.39 | $6.33 | -1.71% |
25-Jun-26 | $6.43 | $6.43 | -0.39% |
24-Jun-26 | $6.37 | $6.46 | +5.56% |
23-Jun-26 | $6.04 | $6.12 | -6.13% |